This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Comparable Results: Achieve cell growth and proteinexpression levels similar to those obtained with smaller-scale shake flasks. On Demand Start Date Tue, 10/29/2024 - 09:00 Don’t miss this opportunity to enhance your scale-up processes with new solutions. Register now to secure your spot!
By Greta Friar, Whitehead Institute June 27, 2024 Images of a mouse brain show the effect of a technology called CHARM in turning off the expression of a gene in the brain. Brain-wide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor. Online June 27, 2024.
Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.
To test whether the mouse-made human ACE2 proteins were functional, the researchers used numerous methods, which included demonstrating that a psuedovirus containing the Covid spike protein could bind to the receptors and infect cells. 2020 March 30 [2024 January 22]; 581:215-220. This study was published in Virology.
Working together will enable the organisations to create a productive interdisciplinary forum that incorporates diverse research interests and experimental approaches, offering their drug discovery and protein science communities the opportunity to connect and share ideas.
By Ari Navetta September 5, 2024 Credit: Allison Colorado, Broad Communications Claudia Ctortecka, a postdoctoral associate in the Proteomics Platform, works with proteomics samples in the lab.
Nominations for the 2024 Merkin Prize opened on September 6, 2023 and close on December 6, 2023 at 11:59 pm ET. Wang concluded her presentation by expressing gratitude to Merkin. For further information on how to nominate for the 2024 Merkin Prize, please visit the prize website.
For example, advances in media and feeds have contributed to higher cell proteinexpression by optimising nutrient availability and reducing accumulation of waste products within a culture. Novel vector design and synthetic promoters have been designed to maximise productivity and enhance gene expression stability.
According to Citeline , there are 160 ALS studies planned or ongoing in 2024 with various sponsors such as academia, consortia, government, and industry, not including studies in HV populations.
Molecular factors Molecular markers, such as proteinexpression and signalling pathway activation, also guide therapy choices. For example, PD-L1 expression predicts the response to immune checkpoint inhibitors. Adaptive Clinical Trial Design in Oncology: An Overview. Clinical Pharmacology & Therapeutics, 86 (1), 97100.
Valentine On November 19, 2024, FDA released a draft guidance titled Frequently Asked Questions Developing Potential Cellular and Gene Therapy Products. Where vector presence is detected, transgene mRNA and/or proteinexpression levels should also be measured. Tobolowsky & Charles G. Raver & James E.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content